尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Große, Dr. Michael, Management Board. Officer active across 1 company, notably Sartorius Aktiengesellschaft. In total, 3 reports have been published. Regulator: BaFin. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Dr. Michael Große is a member of the Management Board at Sartorius Aktiengesellschaft. In this role, he is responsible for overseeing the company's operations and strategy. His expertise in the biopharmaceutical sector enables him to contribute to Sartorius's strategic direction. Michael is committed to improving operational efficiency and strengthening the company's market position.